Brief: Arch Biopartners To Settle $2.6 Million In Deferred Convertible Notes
26/09/2024 13:51
Sept 26 (Reuters) - Arch Biopartners Inc ARCH.V :
* UNITS FOR DEBT SETTLEMENT
* ARCH BIOPARTNERS INC - TO SETTLE $2.6 MILLION IN DEFERRED
CONVERTIBLE NOTES
Source text for Eikon: ID:nGNXbtLRrF
Further company coverage: ARCH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide